Jonathan S. Berek

31.4k total citations · 10 hit papers
297 papers, 16.6k citations indexed

About

Jonathan S. Berek is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Jonathan S. Berek has authored 297 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Reproductive Medicine, 92 papers in Obstetrics and Gynecology and 88 papers in Oncology. Recurrent topics in Jonathan S. Berek's work include Ovarian cancer diagnosis and treatment (146 papers), Endometrial and Cervical Cancer Treatments (73 papers) and Cervical Cancer and HPV Research (34 papers). Jonathan S. Berek is often cited by papers focused on Ovarian cancer diagnosis and treatment (146 papers), Endometrial and Cervical Cancer Treatments (73 papers) and Cervical Cancer and HPV Research (34 papers). Jonathan S. Berek collaborates with scholars based in United States, United Kingdom and Germany. Jonathan S. Berek's co-authors include Neville F. Hacker, William H. Parker, Bradley J. Monk, Sean Kehoe, Michael Friedländer, David S. Alberts, Luís Souhami, Rolland J. Barrett, William A. Peters and Richard J. Stock and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

Jonathan S. Berek

293 papers receiving 16.1k citations

Hit Papers

Concurrent Chemotherapy and Pelvic Radiation Therapy Comp... 1994 2026 2004 2015 2000 2019 1994 2009 2023 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
    2000 1.7k citations William A. Peters, Rolland J. Barrett et al. Journal of Clinical Oncology profile →
  2. Revised FIGO staging for carcinoma of the cervix uteri
    2019 636 citations Neerja Bhatla, Jonathan S. Berek et al. International Journal of Gynecology & Obstetrics profile →
  3. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
    1994 502 citations Jonathan S. Berek et al. American Journal of Obstetrics and Gynecology profile →
  4. Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study
    2009 454 citations William H. Parker, Michael S. Broder et al. Obstetrics and Gynecology profile →
  5. FIGO staging of endometrial cancer: 2023
    2023 412 citations Jonathan S. Berek, Xavier Matías‐Guiu et al. International Journal of Gynecology & Obstetrics profile →
  6. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
    2019 377 citations Masoud Azodi, Amit M. Oza et al. profile →
  7. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
    2021 255 citations Jonathan S. Berek, Sean Kehoe et al. International Journal of Gynecology & Obstetrics profile →
  8. FIGO staging of endometrial cancer: 2023
    2023 112 citations Jonathan S. Berek, Xavier Matías‐Guiu et al. Journal of Gynecologic Oncology profile →
  9. Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
    2023 105 citations Jonathan S. Berek et al. Journal of Clinical Oncology profile →
  10. Germline Genetic Testing After Cancer Diagnosis
    2023 66 citations Allison W. Kurian, Paul Abrahamse et al. profile →

Peers

Jonathan S. Berek
Comparison fields: 5 of 163
  • Reproductive Medicine 8.1k
  • Obstetrics and Gynecology 7.4k
  • Surgery 4.7k
  • Oncology 4.3k
  • Epidemiology 3.2k
Replace Pierluigi Benedetti Panici with:
Pierluigi Benedetti Panici Italy
David G. Mutch United States
Henry C Kitchener United Kingdom
Thomas J. Herzog United States
William T. Creasman United States
Neville F. Hacker Australia
John K. Chan United States
Frédéric Amant Belgium
Robert A. Burger United States
Bradley J. Monk United States
Pierluigi Benedetti Panici Italy View profile →
Citations per field, relative to Jonathan S. Berek
Jonathan S. Berek · 1×
Citations per year, relative to Jonathan S. Berek
Jonathan S. Berek · 1×

Countries citing papers authored by Jonathan S. Berek

Since Specialization
Citations

This map shows the geographic impact of Jonathan S. Berek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Berek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Berek more than expected).

Fields of papers citing papers by Jonathan S. Berek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Berek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Berek. The network helps show where Jonathan S. Berek may publish in the future.

Co-authorship network of co-authors of Jonathan S. Berek

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Berek. A scholar is included among the top collaborators of Jonathan S. Berek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Berek. Jonathan S. Berek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
2023 ·Journal of Clinical Oncology ·William A. Peters, Pengfei Liu, Rolland J. Barrett, Richard J. Stock, Bradley J. Monk, Jonathan S. Berek, Luís Souhami, Perry W. Grigsby, William Gordon, David S. Alberts
13
2
In Vivo Ultrasound Molecular Imaging in the Evaluation of Complex Ovarian Masses: A Practical Guide to Correlation with Ex Vivo Immunohistochemistry
2023 ·Advanced Biology ·(unknown), Huaijun Wang, Ahmed El Kaffas, Terry S. Desser, Ann K. Folkins, Teri A. Longacre, Jonathan S. Berek, A.M. Lutz
1
3
FIGO staging of endometrial cancer: 2023 breakdown →
2023 ·Journal of Gynecologic Oncology ·Jonathan S. Berek, Xavier Matías‐Guiu, Carien L. Creutzberg, Christina Fotopoulou, David K. Gaffney, Sean Kehoe, Kristina Lindemann, David G. Mutch, Nicole Concin
112
4
Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors
2022 ·Seminars in Oncology Nursing ·Catherine Benedict, (unknown), (unknown), Erqi L. Pollom, Lidia Schapira, Allison W. Kurian, Jonathan S. Berek, Oxana Palesh
5
5
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects
2022 ·Cancer Research Communications ·Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, B.J. Rimel, Jørn Herrstedt, Amit M. Oza, Ulrich Canzler, Jonathan S. Berek, Antonio González-Martı́n, (unknown), Rosemary Lord, Masoud Azodi, (unknown), Zebin Wang, Yong Li, Divya Gupta, Ursula A. Matulonis, Bin Feng
5
6
Association of illness mindsets with health-related quality of life in cancer survivors.
2022 ·Health Psychology ·(unknown), Catherine Benedict, Sean R. Zion, (unknown), (unknown), Allison W. Kurian, Jonathan S. Berek, Yohannes W. Woldeamanuel, Lidia Schapira, Oxana Palesh
12
7
Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer
2021 ·JNCI Journal of the National Cancer Institute ·Allison W. Kurian, Paul Abrahamse, Irina Bondarenko, Ann S. Hamilton, Dennis Deapen, Scarlett Lin Gomez, Monica Morrow, Jonathan S. Berek, Timothy P. Hofer, Steven J. Katz, Kevin C. Ward
9
8
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes
2021 ·JCO Precision Oncology ·Allison W. Kurian, Paul Abrahamse, Kevin C. Ward, Ann S. Hamilton, Dennis Deapen, Jonathan S. Berek, Lily Hoang, Amal Yussuf, Jill S. Dolinsky, Krystal Brown, Thomas Slavin, Timothy P. Hofer, Steven J. Katz
5
9
Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors
2021 ·Psycho-Oncology ·Catherine Benedict, (unknown), Lidia Schapira, (unknown), (unknown), Tara M. Sullivan, Erqi L. Pollom, Jonathan S. Berek, Allison W. Kurian, Oxana Palesh
62
10
Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019
2021 ·Journal of Clinical Oncology ·Allison W. Kurian, Kevin C. Ward, Paul Abrahamse, Irina Bondarenko, Ann S. Hamilton, Dennis Deapen, Monica Morrow, Jonathan S. Berek, Timothy P. Hofer, Steven J. Katz
74
11
Revised FIGO staging for carcinoma of the cervix uteri breakdown →
2019 ·International Journal of Gynecology & Obstetrics ·Neerja Bhatla, Jonathan S. Berek, Mauricio Cuello Fredes, Lynette Denny, Seija Grénman, Kanishka Karunaratne, Sean Kehoe, Ikuo Konishi, Alexander Olawaiye, Jaime Prat, Rengaswamy Sankaranarayanan
636
12
Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
2019 ·Journal of Gynecologic Oncology ·Jonathan S. Berek, Koji Matsuo, Brendan H. Grubbs, David K. Gaffney, Susanna I. Lee, (unknown), Gi Jeong Cheon, Chong Woo Yoo, (unknown), (unknown), Tianhui Chen, Miseon Kim, Mikio Mikami
32
13
Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation
2016 ·Journal of Minimally Invasive Gynecology ·Deirdre Lum, Eric R. Sokol, Jonathan S. Berek, Jay Schulkin, Ling Chen, (unknown), Jason D. Wright
39
14
Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study
2013 ·Cancer Immunology Research ·Fiona Simpkins, Aurea E. Flores, Christina Chu, Jonathan S. Berek, Joseph A. Lucci, Sharon C. Murray, John F. Bauman, Herbert Struemper, Fiona Germaschewski, Zdenka Jonak, Olivia Gardner, John Toso, George Coukos
41
15
Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy
2010 ·Obstetrics and Gynecology ·Jonathan S. Berek, Eva Chalas, Mitchell I. Edelson, David H. Moore, William M. Burke, William A. Cliby, Andrew Berchuck
69
16
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study breakdown →
2009 ·Obstetrics and Gynecology ·William H. Parker, Michael S. Broder, Eunice Chang, Diane Feskanich, Cindy Farquhar, (unknown), Donna Shoupe, Jonathan S. Berek, Susan E. Hankinson, JoAnn E. Manson
454
17
Impact of the Human Papilloma Vaccine on Cervical Cancer
2007 ·Journal of Clinical Oncology ·John K. Chan, Jonathan S. Berek
42
18
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix breakdown →
2000 ·Journal of Clinical Oncology ·William A. Peters, (unknown), Rolland J. Barrett, Richard J. Stock, Bradley J. Monk, Jonathan S. Berek, Luís Souhami, Perry W. Grigsby, William Gordon, David S. Alberts
1736
19
Intraperitoneal recombinant α-interferon for “salvage” immunotherapy in stage III epithelial ovarian cancer: A gynecologic oncology group study
1986 ·Seminars in Oncology ·Jonathan S. Berek, Neville F. Hacker, Alan Lichtenstein, (unknown), Celsa A. Spina, Reba M. Knox, J. L. Brady, (unknown), (unknown), Leo D. Lagasse, Eric M. Bonnem, Robert J. Spiegel, Jacob Zighelboim
13
20
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
1986 ·American Journal of Obstetrics and Gynecology ·Jonathan M. Niloff, Robert C. Knapp, Philip T. Lavin, George D. Malkasian, Jonathan S. Berek, Rodrigue Mortel, Charles Whitney, Vincent R. Zurawski, Robert C. Bast
104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierluigi Benedetti Panici Breakdown of academic impact, for papers by David G. Mutch Breakdown of academic impact, for papers by Henry C Kitchener Breakdown of academic impact, for papers by Thomas J. Herzog Breakdown of academic impact, for papers by William T. Creasman Breakdown of academic impact, for papers by Neville F. Hacker Breakdown of academic impact, for papers by John K. Chan Breakdown of academic impact, for papers by Frédéric Amant Breakdown of academic impact, for papers by Robert A. Burger Breakdown of academic impact, for papers by Bradley J. Monk
Rankless by CCL
2026